Company intelligence / Profile preview
Ningbo NewBay Technology Development Co., Ltd.
Ningbo, Zhejiang, Chinaorpha.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Ningbo NewBay Technology Development Co., Ltd. ("NewBay Pharma") is an active Chinese biopharmaceutical company focused on the development and commercialization of innovative oncology therapies. The company's lead asset, GDC‑0570/NB004—a pan-PIM kinase inhibitor licensed from Genentech—is in phase I clinical trials targeting multiple myeloma, prostate cancer, and advanced solid tumors. Additional pipeline assets include novel PARP1 inhibitors for cancer treatment and rights to EP4 antagonists/c-KIT inhibitor programs through partnerships with AskAt Inc. and AstraZeneca. The company operates globally through licensing agreements with major pharma partners such as Genentech/Roche.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesPARP inhibitorsPan-PIM kinase inhibitors
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Genentech/Roche – exclusive global license agreement for GDC‑0570/NB004 development/commercialization.AskAt Inc. – Greater China rights to two EP4 antagonists.AstraZeneca – global right to a c-KIT inhibitor program.
Beyond the preview
Go deeper on Ningbo NewBay Technology Development Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningbo NewBay Technology Development Co., Ltd..